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Anti-DNA antibodies can bind to the glomerulus via two
distinct mechanisms
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Anti-DNA antibodies can bind to the glomerulus via two distinct
mechanisms. It is generally assumed that antibodies to double stranded
DNA (anti-DNA) play a pivotal role in the pathogenesis of SLE
nephritis. Recently, we reported that anti-DNA antibodies can bind to
heparan sulphate proteoglycan (HSPG), a constituent of the glomerular
basement membrane (GBM), via histones and DNA. We postulated that
these histone/DNAIanti-DNA complexes can bind via their histone part
to the glomerulus in vivo. To test this hypothesis we performed in vitro
binding studies with isolated GBM loops and renal perfusion studies in
the rat using histones, DNA and an anti-DNA monoclonal antibody
(mAb) with high avidity for dsDNA. A strong granular binding of
anti-DNA mAb to isolated GBM loops occurred via histones and DNA
and a moderate granular binding was found via DNA alone. Anti-DNA
mAb alone did not bind to the GBM loops. After perfusion of histones,
DNA and immediately thereafter anti-DNA, we found with immuno-
electron microscopy (IEM) a strong binding to endothelial cells in the
glomerulus and to a lesser extent in the GBM. When the anti-DNA mAb
was injected i.v. one hour after perfusion of histones and DNA, we
observed a strong fine granular binding to the capillary wall by
immunofluorescence (IF) in a membranous pattern along with some
minor mesangial deposits. After perfusion of DNA alone followed by
anti-DNA mAb, binding in the glomerulus was less than with histones
and DNA, and was more restricted to the mesangium. No direct binding
to the glomerulus was observed after perfusion with anti-DNA mAb
alone, histones and anti-DNA mAb, or histones, DNA and a control
mAb. It is concluded that anti-DNA mAb can bind to the glomerulus via
histones and DNA, and to a lesser extent via DNA alone. Both
mechanisms may be involved in the development of SLE nephritis.
One of the most severe disease manifestations in patients
with systemic lupus erythematosus (SLE) is the development of
glomerulonephritis. It is generally assumed that complement-
fixing antibodies of the IgG class which bind to dsDNA with
high avidity are involved in the pathogenesis of SLE nephritis
[1J. This assumption is in line with the observation that periods
of active renal disease are associated with elevated levels of
anti-DNA and depression of serum complement levels [2, 3]. In
addition, the presence of anti-DNA antibodies has been identi-
fied in renal or glomerular eluates obtained from SLE patients
or mice with SLE-like syndromes [4—lOll. However, the mech-
anisms responsible for the binding of anti-DNA antibodies to
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the glomerulus are still unclear and have raised some contro-
versies. Several mechanisms have been proposed for the local-
ization of anti-DNA antibodies in the glomerulus. The most
generally accepted hypothesis is the deposition of circulating
DNA-anti-DNA antibody complexes in the glomerulus [11, 12].
This assumption was challenged by studies claiming that anti-
DNA antibodies can bind directly to glomerular antigens due to
cross reactions [8, 9, 13—18]. However, it turned out that these
presumed cross reactions of anti-DNA antibodies with, for
instance cell-surface proteins or heparan sulphate proteoglycan
(HSPG), as a constituent of the GBM, were mediated via
histone/DNA complexes [19, 20]. Based on the findings of
Schmiedeke et al [21], who showed that histones can bind with
high affinity to the GBM in vivo, we recently postulated that
histone/DNA/anti-DNA antibody complexes can bind via their
histone part to the glomerulus [22]. To test this hypothesis we
performed in vitro binding studies with isolated GBM loops and
renal perfusion studies in the rat using histones, DNA and an
anti-DNA monoclonal antibody (mAb) with high avidity for
DNA. In this report we describe two distinct mechanisms of
binding of anti-DNA antibodies to different glomerular struc-
tures.
Methods
Production and purification of monoclonal antibodies to
dsDNA
MAbs to dsDNA were produced as described previously [23].
For this study an anti-DNA clone was selected that was positive
in the anti-DNA ELISA, the Crithidia luciliae assay and the
Farr assay (clone 42), which indicates that this mAb has a high
avidity for dsDNA, as described previously [231. This clone
originates from a (NZBxW)Fl mouse and belongs to the IgG2a
subclass as determined in an Ouchterlony using subclass spe-
cific antibodies (Nordic, Tilburg, The Netherlands). The con-
centration of IgG was determined by radial immunodiffusion
[24]. The mAbs were purified with protein-A sepharose chro-
matography under dissociative conditions to remove potentially
antibody-bound nuclear antigens such as DNA and histones as
described previously [20, 25]. Briefly, mAbs from concentrated
culture supernatant were diluted in buffer with a final concen-
tration of 3 M NaCI, 1.5 M glycine-NaOH, pH 8.9. Subse-
quently, they were applied to a protein-A Sepharose column
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(Pharmacia, Uppsala, Sweden) equilibrated in the above men-
tioned buffer. Bound antibodies were eluted with 0.1 M citric
acid (pH 3.0) and the eluate was dialyzed against PBS.
Isolation of glomerular basement membranes
Glomeruli were isolated from 60 rat kidneys by differential
sieving as described by Spiro [26]. GBM was prepared accord-
ing to the method of Meezan, Hjelle and Brendle [27] with slight
modifications. Briefly, glomerular cells were lysed overnight at
4°C in distilled water containing 0.1% sodium azide. Then, the
lysed glomeruli were spun down at 1000 g and washed three
times with distilled water. The pellet was suspended in 40 ml of
1 M NaC1, stirred for two hours at room temperature, and spun
down at 1000 g; subsequently, the pellet was resuspended in 4%
sodium deoxycholate containing 0.1% sodium azide and stirred
for two hours at room temperature. Then the homogenate was
spun down again, the supernatant discarded and the pellet
washed three times in distilled water. Finally, the obtained
GBM material was treated with DNase I (Boehringer, Mann-
heim, Germany) under high salt conditions (0.1 M acetate pH
5.0 containing 5 m'vi 3 M NaC1 and 320 U/ml DNase I) to
remove DNA and other nuclear material potentially bound to
the GBM. Thereafter, the GBM material was washed with
distilled water and immediately used for in vitro studies or
lyophilized and stored at —20°C. The presence of different
GBM components was studied with indirect IF using several
antisera against GBM components: rabbit anti-mouse laminin
(Gibco, Grand Island, New York, USA), rabbit anti-mouse
collagen IV (Collaborative Research, Bedford, Massachusetts,
USA) and goat anti-mouse fibronectin (Calbiochem, La Jolla,
California, USA). A polyclonal rabbit antiserum directed
against the core protein of HSPG was provided by Dr. L. van
den Heuvel (Dept. of Biochemistry, University of Nijmegen)
[28] and a mAb (JM-403) directed against the heparan sulphate
(HS) side chain of HSPG [29] was a gift of Dr. J. van den Born
(Div. of Nephrology, University Hospital Nijmegen). We ob-
tained a strong staining with antisera to laminin, collagen IV
and fibronectin with the indirect IF, a moderate staining with
the antiserum to the core protein of HSPG but no staining with
a mAb directed against the HS side chain of HSPG. The
isolated GBM showed neither fluorescence after incubation
with ethidium bromide nor with an indirect IF using the high
avidity anti-DNA mAb (clone 42), suggesting that the isolated
GBM loops were free of DNA. To exclude the presence of
histones, GBM loops were treated with 0.1 N HC1 according to
the method of Tan, Robinson and Robitaille [30]. Evaluation
with electron microscopy (EM) revealed that the obtained
fraction consisted of GBM loops with additional mesangial
matrix and was free of cellular components. Anionic sites were
still present as confirmed in the EM by the binding of cationic
ferritin (Miles Laboratories, Elkhart, Indiana, USA).
Binding of anti-DNA mAb to isolated GBM ioops in vitro
GBM loops, suspended in distilled water, embedded in Tis-
sue Tek (Miles Labs) and snap frozen in liquid nitrogen were
cut in 2 sm thick cryostat sections. GBM sections were
successively incubated for 30 minutes at room temperature with
I g/ml histones, 1 tg/ml DNA and purified mAb (2 tg/ml of
clone 42). Calf thymus histones, containing all histone subfrac-
tions, were purchased from Boehringer. Calf thymus DNA was
purchased from Pharmacia (sonicated calf thymus DNA, phe-
nol extracted, A260/A280: 1.84, average size 1500 bases, range
300 to 5000 bases). All solutions were prepared in PBS contain-
ing 1% BSA. After each incubation step the GBM sections were
washed for five minutes in PBS. Finally, sections were incu-
bated for 30 minutes with FITC-labeled sheep anti-mouse IgG,
F(ab)2 antibodies (Cappel-Organon Technika NV, Turnhout,
Belgium). In control experiments GBM loops were incubated
with DNA and mAb, histones and mAb, or with mAb alone.
The same experiments were carried out with an irrelevant
control mAb of the same subclass (clone WT 32 directed against
human CD3).
Production of anti-histone antibodies
The histone fraction H3 (Boehringer) was coupled to keyhole
limpet hemocyanin (KLH) (Calbiochem, San Diego, California,
USA) using m-maleimido-benzoyl-N-hydroxy-succinimide es-
ter (MBS) (Pierce, Rockford, Illinois, USA) as the carrier
molecule as described by Lerner and Green with slight modifi-
cations [311. Briefly, after coupling KLH-MBS in a 1:40 molar
ratio, the KLH-MBS was passed through a Sephadex G-25
column and washed with 0.05 M phosphate buffer, pH 7.2, to
remove free MBS. The histone H3 fraction was coupled to an
equal amount of KLH-MBS by constant stirring for three hours
at room temperature, after which the conjugate was dialyzed
overnight at 4°C against PBS. Rabbits received 1 mg of histone
H3-KLH in complete Freund's adjuvant s.c. and were subse-
quently boosted with 0.25 mg H3-KLH in incomplete Freund's
adjuvant every three weeks for three months. By ELISA the
antibodies showed a strong reactivity with histone H3, but also
reacted to a lesser extent with histone H2a, H2b and H4.
Ex vivo and in vivo renal perfusion studies
To study binding of anti-DNA mAb to the glomerulus we
performed renal perfusion studies using two different methods.
The number of rats used in each experiment is given in Table 2.
The first method, an ex-vivo perfusion procedure, was carried
out in male Wistar rats (150 g), which were anesthetized by i.p.
administration of 0.3 ml (18 mg) sodium pentobarbital (Nar-
covet, Apharmo, Arnhem, The Netherlands), After opening the
peritoneal cavity, an 18 gauge indwelling catheter was inserted
into the aorta above the bifurcation and positioned directly
under the origin of the left renal artery. After removal of the
inner needle the cannula was connected to an infusion system
containing 1% BSA in PBS that was placed 1.2 m above
working level. Immediately thereafter the aorta was ligated
above the left and below the right renal artery, and an incision
was made in the vena cava to allow the escape of blood and
perfusion fluid. After the left kidney had blanched completely,
successively 250 g histones, 250 jsg DNA and 20 sg Ig of clone
42 (ANA titer 1:400) were infused into the left kidney in an ex
vivo perfusion model and each reagent was allowed to bind for
two minutes. After each perfusion step the kidney was flushed
for 30 seconds and after the last perfusion step for five minutes
with PBS containing 1% BSA. Subsequently, a small part of the
kidney was removed and prepared for IF, the remaining part
was perfused with a mixture of periodate, lysine, and 2%
paraformaldehyde (PLP) for 10 minutes and prepared for IEM
(see below). For the second method of perfusion, an in vivo
renal perfusion procedure, a 24-gauge indwelling catheter was
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inserted as described above, however, without incising the vena
cava. The left kidney was first perfused with 0.3 ml of PBS
containing 1% BSA (PBS-1%BSA) to remove blood, followed
by 0.3 ml of a solution containing 250 jsg of histones in
PBS-l%BSA, flushed with 0.3 ml PBS-l%BSA, and subse-
quently perfused with 250 tg of DNA dissolved in 0.3 ml
PBS-l%BSA after which the left kidney was again flushed with
0.3 ml PBS-l%BSA. All solutions were given with the use of an
1 ml syringe at a flow rate of 1 mI/mm and both histones and
DNA were allowed to bind for two minutes. Immediately after
the last perfusion the ligature was removed to reestablish
normal blood flow and the incision in the abdominal wall was
sutured. Then, after one hour anti-DNA mAb (100 to 150 g of
clone 42, ANA titer 1:1000 to 1:2500, dissolved in 1 ml
PBS-l%BSA) was injected i.v. into the tail vein and after 30
minutes the kidneys were prepared for IF and IEM studies. In
control experiments perfusion with histones and DNA was
followed by injection with an irrelevant control mAb of the
same subclass (clone WT 32) or anti-DNA mAb was injected
without previous perfusion with histones and/or DNA.
Immunohistology
After the perfusion experiments 2 m cryostat sections from
kidneys were incubated with a F(ab)2 FITC-labeled sheep
anti-mouse IgG (Cappel-Organon Technika NV, Turnhout,
Belgium) for 30 minutes. After rinsing in PBS, sections were
embedded in Aquamount (BDH Ltd, Poole, England, UK) and
examined with a Leitz fluorescence microscope equipped with
a Ploemopak epiillumination and scored semiquantitatively on a
scale from 0 to 4+. To confirm the binding of histones to the
glomerulus in the ex vivo and in vivo perfusion studies, sections
were also incubated with a polyclonal rabbit anti-histone (H3)
antiserum. After rinsing with PBS, the sections were stained
with FITC-labeled goat anti-rabbit IgG (Kallestad, Austin,
Texas, USA). For IEM studies the left kidneys were perfused
with PLP for 10 minutes, were subsequently removed and small
pieces of renal cortex were immersed in PLP for an additional
three hours. The ultrastructural localization in the glomerulus
of the anti-DNA mAb was visualized by an immunoperoxidase
labeling procedure. Small fragments of renal cortex fixed with
PLP were rinsed several times in PBS, cryoprotected by
immersion in 2.3 M sucrose, buffered with 0.1 M phosphate
buffer (pH 7.2) for one hour, and then frozen in liquid nitrogen.
Twenty jsm sections were incubated with a peroxidase labeled
rabbit anti-mouse IgG (Dakopatt, Copenhagen, Denmark). The
sections were then preincubated with diaminobenzidine (DAB)
medium containing 0.6% Tris for 10 to 15 minutes, followed by
DAB with addition of H202 to a final concentration of 0.001%
for seven minutes. The sections were washed in distilled water,
postfixed in 0.1 M phosphate-buffered 2% 0s04 for 30 minutes
at room temperature, dehydrated, and embedded in Epon 812.
Thin sections were prepared on a LKB ultratome, and exam-
ined unstained in an electron microscope (Philips 300, Eind-
hoven, The Netherlands).
Results
Binding of anti-DNA mAb to isolated GBM loops
The in vitro binding of anti-DNA mAb to isolated GBM was
studied with indirect IF, the results of which are summarized in
Table 1. Binding of an anti-DNA monoclonal antibody to GBM loops
Incubation step GBM
stainingaHistones DNA mAb
—
+
—
+
—
—
+
+
#42
#42
#42
#42
0
0
2+
4+
-
+
—
+
-
—
+
+
WT32
WT32
WT32
WT32
0
0
0
0
a Indirect immunofluorescence on cryostat sections of GBM loops
(scored 0 to 4+): in vitro binding of anti-DNA mAb (clone #42) after
preincubation with histones and/or DNA. Clone WT32 served as a
control mAb.
Table I. The anti-DNA mAb did not bind directly to the GBM
that was treated with DNase I under dissociative conditions of
3 M salt to remove DNA and other nuclear material that might
have contaminated the ioops during the isolation procedure
(Fig. 1A). After preincubation with DNA a moderate granular
binding was observed, while after preincubation with histones
and subsequently DNA, a strong granular binding occurred
(Fig. lB). Additional treatment of the GBM loops with 0.1 N
HC1 previous to the incubations, to extract potentially bound
histones, did not alter the binding of anti-DNA mAb to the
GBM after preincubation of DNA alone. After preincubation
with histones alone no binding could be detected. If an irrele-
vant mAb with the same subclass and Ig concentration was
used (clone WT 32), no binding could be seen neither after
preincubation with histones, nor after DNA, or histones and
DNA, excluding non-specific binding to the GBM.
Binding of anti-DNA mAb to the glomerulus in renal
perfusion studies
The binding of anti-DNA mAb to the glomerulus was studied
in an cx vivo and in an in vivo renal perfusion model (Table 2).
After successive perfusion of histones, DNA and the anti-DNA
mAb directly into the left kidney (ex vivo model), we found a
strong staining of the glomeruli, arteries and peritubular capil-
laries by IF (Fig. 2 A and C). By IEM large aggregates could be
observed on the cell membranes of the glomerular endothelial
cells and to the GBM at the site of the glomerular endothelial
cells (Fig. 2B). Smaller complexes were also seen in the lamina
rara interna, but not on the outer side of the GBM. Further-
more, we found localization on the endothelial cell membranes
of the renal arteries and peritubular capillaries (Fig. 2D). When
DNA was perfused into the kidney followed by anti-DNA mAb,
we also observed binding in the glomerulus, as suggested by IF
(Fig. 3A) predominantly in the mesangium. In the IEM this
binding was indeed exclusively located in mesangial areas,
mostly between endothelial and mesangial cells; no binding was
observed to endothelial cells or in the GBM itself (Fig. 3B).
A different binding pattern to the glomerulus was observed
after the in vivo perfusion procedure in which anti-DNA mAb
clone 42 was administered into the tail vein one hour after the
perfusion of histones and DNA into the left kidney. This time
interval apparently allowed the nuclear components to pene-
trate more deeply into the glomerular capillary wall before they
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Fig. 1. Indirect immunofluorescence on cryostat sections of isolated GBM loops. No binding was found after incubation with mAb alone (A). After
preincubation with histones and subsequently DNA, a strong granular binding was observed with anti-DNA mAb clone 42 (B). (A) 500x; (B)
l000x.
Table 2. Glomerular binding of an anti-DNA monoclonal antibodya
Perfusi
Histones
on
DNA
cx
mes
vivo
CW
in
mes
vivo
CW
— — 0 0 (1) 0 0 (2)
+ — 0 0 (2) 0 0 (3)
— + 2+ 0 (2) 2+ 1+ (5)
+ + 0 4+ (4) 2+ 4+ (5)
Abbreviations are: mes, mesangium; CW, capillary wall. The number
of rats studied are between parentheses.
a Binding of anti-DNA mAb to glomerular components after perfu-
sion with histones and DNA in an cx vivo and in vivo renal perfusion
model (see text). Binding was studied with direct immunofluorescence
and scored semiquantitatively on a scale from 0 to 4+.
served as planted antigens for the subsequently administered
anti-DNA mAb. In the direct IF fine granules were seen along
the capillary wall in a membranous pattern while a variable
amount of deposits were also present in the mesangium (Fig.
2E). The immune deposits in the glomerular capillary wall could
be located in the slit pores and under the foot processes of the
visceral epithelial cells in the direct IEM (Fig. 2F). In contrast
to the cx vivo perfusion procedure, no binding to the endothe-
hal cells of arteries and peritubular capillaries was observed by
direct IF and IEM. When 100 g of anti-DNA clone 42 (titer
:1000) was injected one hour after perfusion of DNA alone into
the left kidney, we found considerably less immune deposits in
the mesangial area than in the ex vivo perfusion model (data not
shown). However, when the amount of anti-DNA mAb injected
after perfusion of DNA was increased (150 g; titer 1:2500), a
strong mesangial binding with a few immune deposits located in
the split pores was observed (Fig. 3 C and D).
In control experiments in which histones were perfused
followed by anti-DNA mAb omitting perfusion of DNA, or in
experiments in which mAb alone was used, in both the cx vivo
and in vivo renal perfusion procedures, we found no binding in
the glomerulus or to blood vessels. In addition, no binding of an
irrelevant mAb could be observed to the glomerulus after
perfusion with histones and DNA (Fig. 3 E and F). Using a
polyclonal anti-histone H3 antiserum we could detect variable
amounts of histones along the capillary wall in both the cx vivo
and the in vivo perfusion model ensuring the binding of the
histones to the glomertilus (Fig. 4).
Discussion
Although it is generally assumed that anti-DNA antibodies
are involved in the induction of SLE nephritis [1], it has been
difficult to induce glomerular binding of these antibodies in
experimental situations. At best, it was only possible to pro-
duce mesangial Ig deposits [15, 17]. Based on our previous
studies [20, 22], we suggested that anti-DNA antibodies can
bind to the GBM by histone/DNA complexes. We examined
this hypothesis by performing in vitro binding studies with
isolated GBM loops and renal perfusion studies in the rat, and
could prove that anti-DNA can indeed bind strongly to the
GBM or the glomerular capillary wall through DNA complexed
to histones. In addition, we found, to our surprise, that anti-
DNA mAb can also bind via DNA alone, although much weaker
than via histones and DNA.
The results of the renal perfusion studies suggest that anti-
DNA antibodies can bind via two mechanisms to two different
glomerular structures, the glomerular capillary wall and the
mesangium, areas in which immune deposits are found in SLE
nephritis. First, anti-DNA antibodies can localize along the
glomerular capillary wall in both renal perfusion procedures
after the consecutive binding of histones and DNA has oc-
curred. In the in vivo perfusion model, in which the mAb was
injected into the tail vein one hour after the renal perfusion of
the nuclear components, a shift of the immune deposits was
observed from the inner side of the capillary wall to the
subepithelial space. It is most likely, that in the cx vivo
perfusion experiments in which the immune deposits were
located on the inner side of the glomerular capillary wall, the
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Fig. 2. Direct immunofluorescence (A, C, E) and immunoelectron microscopy (B, D, F) of the glomerular binding of anti-DNA mAb in renal
perfusion studies in the rat, After successive perfusion of histones, DNA and anti-DNA mAb (clone 42) into the left kidney (ex vivo perfusion
procedure) a strong staining of glomeruli (A), peritubular capillaries and arteries (C) is found by immunofluorescence, Large aggregates are located
on the cell membranes and in the fenestrae of endothelial cells of the glomerulus (B), and peritubular capillaries and arteries (D). Smaller deposits
are also present in the lamina rara interna of the GBM (B) as observed by immunoelectron microscopy. When the anti-DNA mAb (clone 42) is
injected intravenously one hour after renal perfusion of histones and DNA (in vivo perfusion procedure), a membranous binding pattern is observed
in immunofluorescence (E), with immune deposits aggregated in the slit pores and under the visceral epithelial cells as seen in the immunoelectron
microscopy (F). (A) 500x; (B) 14500x; (C) 400x; (D) 3500x; (E) 500x; (F) 28500x.
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Fig. 4. Photornicrograph of the indirect immunofluorescence of a rat
glomerulus showing the presence of histone along the glomerular
capillary wall. Histones, DNA, and anti-DNA mAb (clone 42) were
consecutively perfused into the rat kidney in the ex vivo perfusion
procedure. The histone localization was visualized by a polyclonal
anti-histone antiserum. 360x.
administration of the anti-DNA mAb immediately after the
perfusion of histones and DNA prevented a deeper penetration
and aggregation of the nuclear components into the capillary
wall and the mesangial areas. Secondly, anti-DNA mAb can
bind predominantly to mesangial areas and occasionally to the
capillary wall through DNA alone. Like the in vitro studies with
the GBM loops, the amount of anti-DNA mAb fixed to the
glomerulus by this latter mechanism is considerably less than
the amount bound via histones and DNA. Glomerular localiza-
tion of DNA has been reported previously [32, 33], however, in
these studies the precise localization within the glomerulus was
not analyzed. Possibly only high avidity anti-DNA antibodies,
such as the one used in this study, can localize in the glomerulus
via DNA alone, because if we used a different mAb with lower
avidity for DNA (anti-DNA ELISA and Crithidia luciliae pos-
itive but Fan assay negative) we only observed binding after
perfusion of histones and DNA and not after perfusion of DNA
alone (data not shown). Taken together, these data indicate that
the binding to the GBM via histones and DNA is much stronger,
while binding via DNA alone is quantitatively less important
and is related to the avidity of anti-DNA antibodies.
At present, we are not able to define precisely which GBM
constituents are responsible for the binding of histones and
DNA. Based on our previous studies, HS is a likely candidate
as ligand for histones [14, 20, 21], which is further substantiated
by the work of Schmiedeke et al [21, 34, 35], and Ohnishi et al
[36]. However, our in vitro incubation studies with GBM loops
make it likely that also other anionic sites are probably in-
volved. The relative harsh conditions used to prepare cell and
DNA free GBM loops led to a decrease of HS within the GBM,
since staining with a mAb towards HS became negative (data
not shown). Despite this reduction of HS-associated anionic
sites, we still found a strong binding of cationic ferritin to the
isolated GBM loops, indicating that other anionic sites were still
present. These findings are in accordance with the observations
of Bertolatus and Hunsicker [37], who found that besides HS
other anionic sites like carboxyl groups may be important for
the net negative charge of the GBM.
How DNA is trapped in the mesangium and the capillary wall
also needs further elucidation. A possible candidate responsible
for DNA binding is fibronectin, that is abundantly present in
mesangial areas and to a lesser extent in the GBM [38] and that
has a binding site for DNA [39]. Another extracellular matrix
component which has been suggested to be responsible for
DNA binding in the glomerulus is collagen [40, 41], in particular
collagen type V [42], which is also present in the mesangial
matrix. It is conceivable therefore that during passage of DNA
from the capillary wall to the mesangium, DNA is bound to
fibronectin and/or collagen and subsequently serves as a
planted antigen for anti-DNA antibodies.
Our results indicate that histones can play an important role
in the deposition of anti-DNA antibodies in the glomerular
capillary wall as seen in SLE nephritis, which is underlined by
studies reporting the presence of histones in the immune
deposits in kidneys of SLE mice [35] and in renal biopsies of
SLE patients [43]. These data are corroborated by studies
which showed that positively charged molecules can act as
planted antigen in the glomerulus for subsequent antibody
binding and induction of proteinuria [44—49]. Whether the
glomerular binding of anti-DNA is mediated via in situ immune
complex formation or caused by the binding of circulating
histone/DNA/anti-DNA complexes remains to be determined.
The latter possibility is supported by the recent finding that in
the circulation of SLE patients DNA is present in association
with histones [50]. Furthermore, a study from our laboratory in
a small number of selected SLE patients seems also in favor of
the last possibility, since we found anti-HS reactivity in the
serum, caused by circulating histonefDNAfanti-DNA com-
plexes, prior to the onset of SLE nephritis [51]. As we [20, 22]
and others [19] reported recently, our results can also explain
some of the cross reactions with intrinsic glomerular antigens
described in the past [8, 9, 13, 18]. Antibodies used in these
studies were not purified under dissociative conditions and it is
conceivable therefore that their potency to bind to the glomer-
ulus was due to histone/DNA particles bound to the antibody.
In summary, this study confirms our previous findings that
anti-DNA antibodies do not bind directly to renal antigens due
to cross reactions [20, 22, 25], but that the binding to the GBM
is mediated via histones and DNA. Furthermore, we could
show that especially high avidity anti-DNA mAb can also bind
particularly to mesangial areas via DNA alone. Binding via both
mechanisms may be operative in the pathogenesis of SLE
nephritis and might offer an explanation for the variability in
renal histopathology, which is a major characteristic of SLE
nephritis.
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